What Enzyme Breaks Down Ach

Primary cholinesterase in the trunk

"Ache" redirects here. For other uses, see Ache.

acetylcholinesterase
Acetylcholinesterase catalyzes the hydrolysis of acetylcholine to acetate ion and choline
Identifiers
EC no.	3.1.i.7
CAS no.	9000-81-1
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Gene Ontology	AmiGO / QuickGO
Search PMC manufactures PubMed articles NCBI proteins

ACHE
Bachelor structures PDB Ortholog search: PDBe RCSB List of PDB id codes 4EY7, 4PQE, 1F8U, 3LII, 4BDT, 4M0E, 4M0F, 1VZJ, 2X8B, 1B41, 4EY4, 4EY5, 4EY6, 4EY8, 5FOQ, 5HF9, 5HF6, 5FPQ, 5HF8, 5HFA
Identifiers
Aliases	Anguish, AChE, acetylhydrolase, acetylcholinesterase (Yt claret group), ACEE, ARN-YT, acetylcholinesterase (Cartwright blood group), true cholinesterase (dated synonym)
External IDs	OMIM: 100740 MGI: 87876 HomoloGene: 543 GeneCards: ACHE
Gene location (Man) Chr. Chromosome 7 (human)[1] Ring 7q22.i Kickoff 100,889,994 bp[1] Cease 100,896,974 bp[1]
Gene location (Mouse) Chr. Chromosome 5 (mouse)[ii] Band 5 G2|5 76.32 cM Start 137,285,781 bp[2] End 137,292,728 bp[2]
RNA expression design Bgee Human Mouse (ortholog) Top expressed in hypothalamus gastrocnemius muscle nucleus accumbens triceps brachii muscle putamen caudate nucleus biceps brachii prefrontal cortex cingulate gyrus pons Peak expressed in medulla oblongata pons os marrow superior colliculus hypothalamus cerebellar cortex inferior colliculus superior frontal gyrus olfactory bulb prefrontal cortex More reference expression data BioGPS More than reference expression data
Cistron ontology Molecular role protein homodimerization action collagen binding acetylcholine binding serine hydrolase activity carboxylic ester hydrolase activity amyloid-beta bounden cholinesterase activity poly peptide cocky-association poly peptide binding laminin bounden hydrolase activity Anguish acetylcholinesterase activity Cellular component Golgi apparatus membrane plasma membrane synapse extracellular region prison cell surface cell junction perinuclear region of cytoplasm anchored component of membrane nucleus synaptic fissure extracellular space neuromuscular junction basement membrane Biological procedure muscle organ development receptor internalization neurotransmitter biosynthetic process negative regulation of synaptic transmission, cholinergic amyloid precursor protein metabolic procedure protein tetramerization acetylcholine catabolic process nervous arrangement evolution neurotransmitter catabolic process DNA replication jail cell adhesion retina development in photographic camera-blazon eye response to wounding positive regulation of protein secretion osteoblast development synapse assembly phosphatidylcholine biosynthetic process regulation of receptor recycling jail cell population proliferation acetylcholine catabolic process in synaptic cleft positive regulation of cold-induced thermogenesis Sources:Amigo / QuickGO
Orthologs Species Man Mouse Entrez 43 11423 Ensembl ENSG00000087085 ENSMUSG00000023328 UniProt P22303 P21836 RefSeq (mRNA) NM_000665 NM_001282449 NM_001302621 NM_001302622 NM_015831 NM_001367915 NM_001367917 NM_001367918 NM_001367919 NM_001290010 NM_009599 RefSeq (protein) NP_000656 NP_001269378 NP_001289550 NP_001289551 NP_001354844 NP_001354846 NP_001354847 NP_001354848 NP_001276939 NP_033729 Location (UCSC) Chr 7: 100.89 – 100.9 Mb Chr v: 137.29 – 137.29 Mb PubMed search [3] [4]
Wikidata
View/Edit Homo View/Edit Mouse

Acetylcholinesterase (HGNC symbol Anguish; EC 3.1.1.7; systematic proper name acetylcholine acetylhydrolase), likewise known as AChE, AChase or acetylhydrolase, is the primary cholinesterase in the torso. Information technology is an enzyme that catalyzes the breakdown of acetylcholine and some other choline esters that function as neurotransmitters:

acetylcholine + H_twoO = choline + acetate

It is found at mainly neuromuscular junctions and in chemic synapses of the cholinergic type, where its action serves to terminate synaptic transmission. It belongs to the carboxylesterase family unit of enzymes. It is the primary target of inhibition by organophosphorus compounds such equally nerve agents and pesticides.

Enzyme structure and machinery [edit]

AChe mechanism of action^[v]

Anguish is a hydrolase that hydrolyzes choline esters. It has a very loftier catalytic activeness—each molecule of Ache degrades about 25,000 molecules of acetylcholine (ACh) per second, approaching the limit allowed by diffusion of the substrate.^{[6] [7]} The active site of AChE comprises 2 subsites—the anionic site and the esteratic subsite. The structure and mechanism of activeness of Ache have been elucidated from the crystal structure of the enzyme.^{[eight] [nine]}

The anionic subsite accommodates the positive fourth amine of acetylcholine likewise as other cationic substrates and inhibitors. The cationic substrates are non bound by a negatively charged amino acid in the anionic site, but by interaction of 14 aromatic residues that line the gorge leading to the active site.^{[x] [xi] [12]} All 14 amino acids in the aromatic gorge are highly conserved across different species.^[xiii] Amongst the aromatic amino acids, tryptophan 84 is critical and its substitution with alanine results in a 3000-fold decrease in reactivity.^[14] The gorge penetrates halfway through the enzyme and is approximately 20 angstroms long. The active site is located 4 angstroms from the bottom of the molecule.^[xv]

The esteratic subsite, where acetylcholine is hydrolyzed to acetate and choline, contains the catalytic triad of three amino acids: serine 203, histidine 447 and glutamate 334. These three amino acids are similar to the triad in other serine proteases except that the glutamate is the third member rather than aspartate. Moreover, the triad is of opposite chirality to that of other proteases.^[sixteen] The hydrolysis reaction of the carboxyl ester leads to the formation of an acyl-enzyme and free choline. And so, the acyl-enzyme undergoes nucleophilic attack by a water molecule, assisted by the histidine 440 group, liberating acetic acid and regenerating the free enzyme.^{[17] [18]}

Biological part [edit]

During neurotransmission, ACh is released from the presynaptic neuron into the synaptic crevice and binds to ACh receptors on the post-synaptic membrane, relaying the signal from the nerve. AChE, also located on the post-synaptic membrane, terminates the point manual by hydrolyzing ACh. The liberated choline is taken up once more by the pre-synaptic neuron and ACh is synthesized past combining with acetyl-CoA through the action of choline acetyltransferase.^{[19] [xx]}

A cholinomimetic drug disrupts this process by acting every bit a cholinergic neurotransmitter that is impervious to acetylcholinesterase'southward lysing activeness.

Disease relevance [edit]

Drugs or toxins that inhibit AChE pb to persistence of high concentrations of ACh within synapses, leading to increased cholinergic signaling inside the primal nervous system, autonomic ganglia and neuromuscular junctions.^[21]

Mechanism of Inhibitors of Anguish

Irreversible inhibitors of Ache may lead to muscular paralysis, convulsions, bronchial constriction, and expiry by asphyxiation. Organophosphates (OP), esters of phosphoric acrid, are a class of irreversible AChE inhibitors.^[22] Cleavage of OP by AChE leaves a phosphoryl group in the esteratic site, which is tiresome to exist hydrolyzed (on the club of days) and can become covalently spring. Irreversible Ache inhibitors have been used in insecticides (e.g., malathion) and nervus gases for chemical warfare (due east.grand., Sarin and Soman). Carbamates, esters of Due north-methyl carbamic acid, are AChE inhibitors that hydrolyze in hours and have been used for medical purposes (eastward.g., physostigmine for the treatment of glaucoma). Reversible inhibitors occupy the esteratic site for brusque periods of time (seconds to minutes) and are used to treat of a range of primal nervous system diseases. Tetrahydroaminoacridine (THA) and donepezil are FDA-approved to better cognitive role in Alzheimer'due south illness. Rivastigmine is also used to care for Alzheimer's and Lewy body dementia, and pyridostigmine bromide is used to care for myasthenia gravis.^{[23] [24] [25] [26] [27] [28]}

An endogenous inhibitor of AChE in neurons is Mir-132 microRNA, which may limit inflammation in the encephalon by silencing the expression of this poly peptide and allowing ACh to act in an anti-inflammatory capacity.^[29]

It has besides been shown that the main active ingredient in cannabis, tetrahydrocannabinol, is a competitive inhibitor of acetylcholinesterase.^[thirty]

Distribution [edit]

Ache is found in many types of conducting tissue: nerve and musculus, fundamental and peripheral tissues, motor and sensory fibers, and cholinergic and noncholinergic fibers. The activity of AChE is higher in motor neurons than in sensory neurons.^{[31] [32] [33]}

Acetylcholinesterase is also plant on the carmine claret jail cell membranes, where different forms found the Yt blood group antigens.^[34] Acetylcholinesterase exists in multiple molecular forms, which possess similar catalytic properties, but differ in their oligomeric associates and fashion of zipper to the cell surface.

AChE gene [edit]

In mammals, acetylcholinesterase is encoded by a single AChE gene while some invertebrates accept multiple acetylcholinesterase genes. Note higher vertebrates also encode a closely related paralog BCHE (butyrylcholinesterase) with 50% amino acid identity to ACHE.^[35] Diverseness in the transcribed products from the sole mammalian gene arises from alternative mRNA splicing and mail-translational associations of catalytic and structural subunits. In that location are 3 known forms: T (tail), R (read through), and H (hydrophobic).^[36]

AChE_T [edit]

The major class of acetylcholinesterase found in encephalon, muscle, and other tissues, known equally is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. In the neuromuscular junctions Ache expresses in asymmetric form which associates with ColQ or subunit. In the central nervous organization it is associated with PRiMA which stands for Proline Rich Membrane anchor to course symmetric form. In either case, the ColQ or PRiMA anchor serves to maintain the enzyme in the intercellular junction, ColQ for the neuromuscular junction and PRiMA for synapses.

AChE_H [edit]

The other, alternatively spliced form expressed primarily in the erythroid tissues, differs at the C-terminus, and contains a cleavable hydrophobic peptide with a PI-anchor site. It associates with membranes through the phosphoinositide (PI) moieties added mail service-translationally.^[37]

AChE_R [edit]

The third type has, and so far, only been found in Torpedo sp. and mice although it is hypothesized in other species. Information technology is thought to be involved in the stress response and, mayhap, inflammation.^[38]

Nomenclature [edit]

The nomenclatural variations of ACHE and of cholinesterases by and large are discussed at Cholinesterase § Types and classification.

Inhibitors [edit]

For acetylcholine esterase (AChE), reversible inhibitors are those that do not irreversibly bail to and deactivate AChE.^[39] Drugs that reversibly inhibit acetylcholine esterase are being explored as treatments for Alzheimer's disease and myasthenia gravis, among others. Examples include tacrine and donepezil.^[40]

Exposure to acetylcholinesterase inhibitors is one of several studied explanations for the chronic cerebral symptoms veterans displayed after returning from the Gulf War. Soldiers were dosed with AChEI pyridostigmine bromide (PB) equally protection from nerve agent weapons. Studying acetylcholine levels using microdialysis and HPLC-ECD, researchers at the University of Southward Carolina School of Medicine determined Pb, when combined with a stress element can lead to cognitive responses.^[41]

See also [edit]

•  Biology portal
• Cholinesterases

References [edit]

1. ^ ^{a b c} GRCh38: Ensembl release 89: ENSG00000087085 - Ensembl, May 2017
2. ^ ^{a b c} GRCm38: Ensembl release 89: ENSMUSG00000023328 - Ensembl, May 2017
3. ^ "Human PubMed Reference:". National Center for Biotechnology Data, U.Due south. National Library of Medicine.
4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. ^ Katzung, BG (2001). "Introduction to Autonomic Pharmacology". Basic and Clinical Pharmacology (8th ed.). McGraw-Hill. pp. 75–91. ISBN978-0-07-160405-5.
6. ^ Quinn DM (1987). "Acetylcholinesterase: enzyme construction, reaction dynamics, and virtual transition states". Chemical Reviews. 87 (5): 955–79. doi:10.1021/cr00081a005.
7. ^ Taylor P, Radić Z (1994). "The cholinesterases: from genes to proteins". Annual Review of Pharmacology and Toxicology. 34: 281–320. doi:10.1146/annurev.pa.34.040194.001433. PMID 8042853.
8. ^ Sussman JL, Harel 1000, Frolow F, Oefner C, Goldman A, Toker 50, Silman I (August 1991). "Atomic construction of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding poly peptide". Science. 253 (5022): 872–9. Bibcode:1991Sci...253..872S. doi:10.1126/science.1678899. PMID 1678899. S2CID 28833513.
9. ^ Sussman JL, Harel M, Silman I (June 1993). "Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs". Chem. Biol. Collaborate. 87 (1–3): 187–97. doi:10.1016/0009-2797(93)90042-W. PMID 8343975.
10. ^ Radić Z, Gibney One thousand, Kawamoto S, MacPhee-Quigley K, Bongiorno C, Taylor P (Oct 1992). "Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants". Biochemistry. 31 (twoscore): 9760–7. doi:x.1021/bi00155a032. PMID 1356436.
11. ^ Ordentlich A, Barak D, Kronman C, Ariel N, Segall Y, Velan B, Shafferman A (Feb 1995). "Contribution of effluvious moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase". J. Biol. Chem. 270 (5): 2082–91. doi:ten.1074/jbc.270.five.2082. PMID 7836436.
12. ^ Ariel Northward, Ordentlich A, Barak D, Bino T, Velan B, Shafferman A (Oct 1998). "The 'aromatic patch' of 3 proximal residues in the homo acetylcholinesterase active center allows for versatile interaction modes with inhibitors". Biochem. J. 335 (ane): 95–102. doi:10.1042/bj3350095. PMC1219756. PMID 9742217.
13. ^ Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen South, Velan B, Shafferman A (Baronial 1993). "Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket". J. Biol. Chem. 268 (23): 17083–95. doi:10.1016/S0021-9258(19)85305-X. PMID 8349597.
14. ^ Tougu V (2001). "Acetylcholinesterase: Mechanism of Catalysis and Inhibition". Electric current Medicinal Chemistry-Key Nervous Organization Agents. i (ii): 155–170. doi:10.2174/1568015013358536.
15. ^ Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL (1993). "Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase". Proceedings of the National Academy of Sciences of the Us of America. 90 (19): 9031–5. Bibcode:1993PNAS...90.9031H. doi:10.1073/pnas.90.19.9031. PMC47495. PMID 8415649.
16. ^ Tripathi A (Oct 2008). "Acetylcholinsterase: A Versatile Enzyme of Nervous Organization". Annals of Neurosciences. fifteen (4): 106–111. doi:10.5214/ans.0972.7531.2008.150403.
17. ^ Pauling L (1946). "Molecular Architecture and Biological Reactions" (PDF). Chemical & Engineering News. 24 (ten): 1375–1377. doi:10.1021/cen-v024n010.p1375.
18. ^ Fersht A (1985). Enzyme structure and mechanism. San Francisco: W.H. Freeman. p. 14. ISBN0-7167-1614-3.
19. ^ Whittaker VP (1990). "The Contribution of Drugs and Toxins to Agreement of Cholinergic Role" (PDF). Trends in Pharmacological Sciences. 11 (ane): viii–13. doi:10.1016/0165-6147(90)90034-6. hdl:11858/00-001M-0000-0013-0E8C-5. PMID 2408211.
20. ^ Purves D, Augustine GJ, Fitzpatrick D, Hall WC, LaMantia As, McNamara JO, White LE (2008). Neuroscience (quaternary ed.). Sinauer Assembly. pp. 121–ii. ISBN978-0-87893-697-7.
21. ^ English, Brett A.; Webster, Andrew A. (2012). "Acetylcholinesterase and its Inhibitors". Primer on the Autonomic Nervous System. Elsevier. pp. 631–633. doi:10.1016/b978-0-12-386525-0.00132-3. ISBN978-0-12-386525-0.
22. ^ "National Pesticide Data Center-Diazinon Technical Fact Sail" (PDF) . Retrieved 24 February 2012.
23. ^ "Clinical Application: Acetylcholine and Alzheimer'southward Disease". Retrieved 24 Feb 2012.
24. ^ Stoelting RK (1999). Anticholinesterase Drugs and Cholinergic Agonists", in Pharmacology and Physiology in Anesthetic Practise. Lippincott-Raven. ISBN978-0-7817-5469-9. Archived from the original on 2016-03-03. Retrieved 2012-02-26 .
25. ^ Taylor P, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (1996). "5: Autonomic Pharmacology: Cholinergic Drugs". The Pharmacologial Basis of Therapeutics. THe McGraw-Colina Companies. pp. 161–174. ISBN978-0-07-146804-6. Archived from the original on 2016-03-04. Retrieved 2012-02-26 .
26. ^ Blumenthal D, Brunton L, Goodman LS, Parker K, Gilman A, Lazo JS, Buxton I (1996). "5: Autonomic Pharmacology: Cholinergic Drugs". Goodman & Gilman's The pharmacological basis of therapeutics. New York: McGraw-Hill. p. 1634. ISBN978-0-07-146804-6.
27. ^ Drachman DB, Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (1998). Harrison's Principles of Internal Medicine (14 ed.). The McCraw-Hill Companies. pp. 2469–2472. ISBN978-0-07-020291-7.
28. ^ Raffe RB (2004). Autonomic and Somatic Nervous Systems in Netter's Illustrated Pharmacology. Elsevier Health Science. p. 43. ISBN978-1-929007-60-8.
29. ^ Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H (2009). "MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase". Immunity. 31 (vi): 965–73. doi:10.1016/j.immuni.2009.09.019. PMID 20005135.
30. ^ Eubanks LM, Rogers CJ, Beuscher AE, Koob GF, Olson AJ, Dickerson TJ, Janda KD (2006). "A molecular link betwixt the active component of marijuana and Alzheimer'south disease pathology". Mol. Pharm. 3 (6): 773–7. doi:x.1021/mp060066m. PMC2562334. PMID 17140265.
31. ^ Massoulié J, Pezzementi Fifty, Bon S, Krejci E, Vallette FM (July 1993). "Molecular and cellular biology of cholinesterases". Progress in Neurobiology. 41 (ane): 31–91. doi:10.1016/0301-0082(93)90040-Y. PMID 8321908. S2CID 21601586.
32. ^ Chacko LW, Cerf JA (1960). "Histochemical localization of cholinesterase in the amphibian spinal cord and alterations following ventral root section". Journal of Anatomy. 94 (Pt 1): 74–81. PMC1244416. PMID 13808985.
33. ^ Koelle GB (1954). "The histochemical localization of cholinesterases in the central nervous organisation of the rat". Journal of Comparative Anatomy. 100 (1): 211–35. doi:x.1002/cne.901000108. PMID 13130712. S2CID 23021010.
34. ^ Bartels CF, Zelinski T, Lockridge O (May 1993). "Mutation at codon 322 in the human acetylcholinesterase (Ache) cistron accounts for YT claret grouping polymorphism". Am. J. Hum. Genet. 52 (5): 928–36. PMC1682033. PMID 8488842.
35. ^ Johnson Thousand, Moore SW (2012). "Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene. 2012". Neurochem. Int. sixteen (v): 783–797. doi:x.1016/j.neuint.2012.06.016. PMID 22750491. S2CID 39348660.
36. ^ Massoulié J, Perrier N, Noureddine H, Liang D, Bon S (2008). "Quondam and new questions about cholinesterases". Chem. Biol. Interact. 175 (1–three): 30–44. doi:ten.1016/j.cbi.2008.04.039. PMID 18541228.
37. ^ "Entrez Gene: Ache acetylcholinesterase (Yt blood group)".
38. ^ Dori A, Ifergane G, Saar-Levy T, Bersudsky M, Mor I, Soreq H, Wirguin I (2007). "Readthrough acetylcholinesterase in inflammation-associated neuropathies". Life Sci. 80 (24–25): 2369–74. doi:10.1016/j.lfs.2007.02.011. PMID 17379257.
39. ^ Millard CB, Kryger K, Ordentlich A, Greenblatt HM, Harel M, Raves ML, Segall Y, Barak D, Shafferman A, Silman I, Sussman JL (June 1999). "Crystal structures of anile phosphonylated acetylcholinesterase: nerve amanuensis reaction products at the atomic level". Biochemistry. 38 (22): 7032–9. doi:ten.1021/bi982678l. PMID 10353814.
40. ^ Julien RM, Advokat CD, Comaty JE (2007-10-12). A Primer of Drug Action (Eleventh ed.). Worth Publishers. pp. l. ISBN978-ane-4292-0679-ii.
41. ^ Macht VA, Woodruff JL, Maissy ES, Grillo CA, Wilson MA, Fadel JR, Reagan LP (August 2019). "Pyridostigmine bromide and stress interact to impact allowed function, cholinergic neurochemistry and behavior in a rat model of Gulf War Illness". Brain, Beliefs, and Immunity. 80: 384–393. doi:10.1016/j.bbi.2019.04.015. PMC6790976. PMID 30953774.

Further reading [edit]

• Silman I, Futerman AH (1988). "Modes of attachment of acetylcholinesterase to the surface membrane". Eur. J. Biochem. 170 (1–2): eleven–22. doi:10.1111/j.1432-1033.1987.tb13662.x. PMID 3319614.
• Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). "Atomic construction of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein". Science. 253 (5022): 872–9. Bibcode:1991Sci...253..872S. doi:ten.1126/science.1678899. PMID 1678899. S2CID 28833513.
• Soreq H, Seidman S (2001). "Acetylcholinesterase--new roles for an quondam actor". Nature Reviews Neuroscience. ii (4): 294–302. doi:10.1038/35067589. PMID 11283752. S2CID 5947744.
• Shen T, Tai K, Henchman RH, McCammon JA (2003). "Molecular dynamics of acetylcholinesterase". Acc. Chem. Res. 35 (6): 332–xl. doi:ten.1021/ar010025i. PMID 12069617.
• Pakaski Chiliad, Kasa P (2003). "Role of acetylcholinesterase inhibitors in the metabolism of amyloid precursor protein". Current Drug Targets. CNS and Neurological Disorders. two (three): 163–71. doi:10.2174/1568007033482869. PMID 12769797.
• Meshorer E, Soreq H (2006). "Virtues and woes of Anguish alternative splicing in stress-related neuropathologies". Trends Neurosci. 29 (4): 216–24. doi:ten.1016/j.tins.2006.02.005. PMID 16516310. S2CID 18983474.
• Ehrlich G, Viegas-Pequignot Due east, Ginzberg D, Sindel Fifty, Soreq H, Zakut H (1992). "Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid prison cell panel and chromosome-sorted DNA libraries". Genomics. 13 (4): 1192–7. doi:x.1016/0888-7543(92)90037-Due south. PMID 1380483.
• Spring FA, Gardner B, Anstee DJ (1992). "Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase". Blood. fourscore (8): 2136–41. doi:10.1182/blood.V80.viii.2136.2136. PMID 1391965.
• Shafferman A, Kronman C, Flashner Y, Leitner Thou, Grosfeld H, Ordentlich A, Gozes Y, Cohen S, Ariel N, Barak D (1992). "Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic action and in polypeptide folding". J. Biol. Chem. 267 (25): 17640–8. doi:10.1016/S0021-9258(19)37091-7. PMID 1517212.
• Getman DK, Eubanks JH, Camp S, Evans GA, Taylor P (1992). "The man gene encoding acetylcholinesterase is located on the long arm of chromosome 7". Am. J. Hum. Genet. 51 (one): 170–seven. PMC1682883. PMID 1609795.
• Li Y, Military camp S, Rachinsky TL, Getman D, Taylor P (1992). "Factor structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression". J. Biol. Chem. 266 (34): 23083–90. doi:ten.1016/S0021-9258(18)54466-5. PMID 1744105.
• Velan B, Grosfeld H, Kronman C, Leitner One thousand, Gozes Y, Lazar A, Flashner Y, Marcus D, Cohen S, Shafferman A (1992). "The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant". J. Biol. Chem. 266 (35): 23977–84. doi:ten.1016/S0021-9258(18)54380-5. PMID 1748670.
• Soreq H, Ben-Aziz R, Prody CA, Seidman Due south, Gnatt A, Neville L, Lieman-Hurwitz J, Lev-Lehman E, Ginzberg D, Lipidot-Lifson Y (1991). "Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure". Proceedings of the National University of Sciences of the U.s.a.. 87 (24): 9688–92. Bibcode:1990PNAS...87.9688S. doi:10.1073/pnas.87.24.9688. PMC55238. PMID 2263619.
• Chhajlani 5, Derr D, Earles B, Schmell E, Baronial T (1989). "Purification and partial amino acid sequence analysis of human being erythrocyte acetylcholinesterase". FEBS Lett. 247 (2): 279–82. doi:10.1016/0014-5793(89)81352-3. PMID 2714437. S2CID 41843002.
• Lapidot-Lifson Y, Prody CA, Ginzberg D, Meytes D, Zakut H, Soreq H (1989). "Coamplification of human being acetylcholinesterase and butyrylcholinesterase genes in claret cells: correlation with various leukemias and abnormal megakaryocytopoiesis". Proceedings of the National Academy of Sciences of the The states of America. 86 (12): 4715–9. Bibcode:1989PNAS...86.4715L. doi:10.1073/pnas.86.12.4715. PMC287342. PMID 2734315.
• Bazelyansky M, Robey East, Kirsch JF (1986). "Partial diffusion-limited component of reactions catalyzed by acetylcholinesterase". Biochemistry. 25 (ane): 125–30. doi:10.1021/bi00349a019. PMID 3954986.
• Gaston SM, Marchase RB, Jakoi ER (1982). "Brain ligatin: a membrane lectin that binds acetylcholinesterase". J. Cell. Biochem. 18 (4): 447–59. doi:10.1002/jcb.1982.240180406. PMID 7085778. S2CID 22975039.
• Ordentlich A, Barak D, Kronman C, Ariel N, Segall Y, Velan B, Shafferman A (1995). "Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase". J. Biol. Chem. 270 (5): 2082–91. doi:10.1074/jbc.270.v.2082. PMID 7836436.
• Maruyama K, Sugano S (1994). "Oligo-capping: a unproblematic method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Ben Aziz-Aloya R, Sternfeld M, Soreq H (1994). "Promoter elements and alternative splicing in the human Anguish gene". Prog. Brain Res. 98: 147–53. doi:10.1016/s0079-6123(08)62392-4. PMID 8248502.
• Massoulié J, Pezzementi Fifty, Bon South, Krejci Eastward, Vallette FM (1993). "Molecular and Cellular Biology of Cholinesterases". Prog. Brain Res. 41 (1): 31–91. doi:10.1016/0301-0082(93)90040-Y. PMID 8321908. S2CID 21601586.

External links [edit]

• ATSDR Case Studies in Environmental Medicine: Cholinesterase Inhibitors, Including Insecticides and Chemical Warfare Nerve Agents U.S. Department of Wellness and Human Services
• Proteopedia Acetylcholinesterase
• Proteopedia AChE_inhibitors_and_substrates
• Proteopedia AChE_inhibitors_and_substrates_(Part_II)
• Proteopedia Anguish bivalent inhibitors AChE_bivalent_inhibitors AChE bivalent inhibitors
• Acetylcholinesterase: A gorge-ous enzyme—PDBe
• Acetylcholinesterase—RCSB PDB
• Human ACHE genome location and Anguish gene details page in the UCSC Genome Browser.
• Overview of all the structural information available in the PDB for UniProt: P22303 (Human Acetylcholinesterase) at the PDBe-KB.

What Enzyme Breaks Down Ach,

Source: https://en.wikipedia.org/wiki/Acetylcholinesterase

Posted by: tyrephost1941.blogspot.com

Share this post